She received her MHS and PhD from the Department of InternationalHealth at Johns Hopkins Bloomberg School of Public Health. She is a health economist whose workfocuses on generating evidence to improve access to vaccines and quality medicines. She interested inthe interface between pharmacy and public health, conducting research on the value of vaccines andthe economic impact of substandard and falsified medicines.